The B cell transcription program mediates hypomethylation and overexpression of key genes in Epstein-Barr virus-associated proliferative conversion

BackgroundEpstein-Barr virus (EBV) infection is a well characterized etiopathogenic factor for a variety of immune-related conditions, including lymphomas, lymphoproliferative disorders and autoimmune diseases. EBV-mediated transformation of resting B cells to proliferating lymphoblastoid cells occurs in early stages of infection and is an excellent model for investigating the mechanisms associated with acquisition of unlimited growth.ResultsWe investigated the effects of experimental EBV infection of B cells on DNA methylation profiles by using high-throughput analysis. Remarkably, we observed hypomethylation of around 250 genes, but no hypermethylation. Hypomethylation did not occur at repetitive sequences, consistent with the absence of genomic instability in lymphoproliferative cells. Changes in methylation only occurred after cell divisions started, without the participation of the active demethylation machinery, and were concomitant with acquisition by B cells of the ability to proliferate. Gene Ontology analysis, expression profiling, and high-throughput analysis of the presence of transcription factor binding motifs and occupancy revealed that most genes undergoing hypomethylation are active and display the presence of NF-κB p65 and other B cell-specific transcription factors. Promoter hypomethylation was associated with upregulation of genes relevant for the phenotype of proliferating lymphoblasts. Interestingly, pharmacologically induced demethylation increased the efficiency of transformation of resting B cells to lymphoblastoid cells, consistent with productive cooperation between hypomethylation and lymphocyte proliferation.ConclusionsOur data provide novel clues on the role of the B cell transcription program leading to DNA methylation changes, which we find to be key to the EBV-associated conversion of resting B cells to proliferating lymphoblasts.

[1]  Alexander E. Kel,et al.  TRANSFAC®: transcriptional regulation, from patterns to profiles , 2003, Nucleic Acids Res..

[2]  Jian-Bing Fan,et al.  Human embryonic stem cells have a unique epigenetic signature. , 2006, Genome research.

[3]  R. Kastelein,et al.  Differential Effects of IL-27 on Human B Cell Subsets1 , 2006, The Journal of Immunology.

[4]  David S. Lapointe,et al.  ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data , 2010, BMC Bioinformatics.

[5]  S. Batalov,et al.  A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Licht,et al.  DNMT3A mutations in acute myeloid leukemia , 2011, Nature Genetics.

[7]  A. Rickinson,et al.  Methylation Status of theEpstein-Barr Virus (EBV) BamHI W Latent Cycle Promoter and Promoter Activity: Analysis with Novel EBV-Positive Burkitt and LymphoblastoidCell Lines , 2006, Journal of Virology.

[8]  Qiong Shen,et al.  Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination , 2006, Nature Immunology.

[9]  J. Minárovits,et al.  Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus. , 2008, The Journal of general virology.

[10]  R. Siebert,et al.  Array-based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B cell-specific genes , 2012, Leukemia.

[11]  Wange Lu,et al.  Identification of preferential target sites for human DNA methyltransferases , 2010, Nucleic Acids Res..

[12]  Michael A. Freitas,et al.  Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL) , 2012, Proceedings of the National Academy of Sciences.

[13]  O. Abdel-Wahab,et al.  The role of mutations in epigenetic regulators in myeloid malignancies , 2012, Nature Reviews Cancer.

[14]  J. Strominger,et al.  Epstein-barr Virus Promoters Regulates the Host-cell-determined Methylation of Specific , 1997 .

[15]  Christian B. Woods,et al.  Analysis of repetitive element DNA methylation by MethyLight , 2005, Nucleic acids research.

[16]  E. Cesarman,et al.  NF-kappaB signaling modulation by EBV and KSHV. , 2010, Trends in microbiology.

[17]  Nuria Lopez-Bigas,et al.  Gitools: Analysis and Visualisation of Genomic Data Using Interactive Heat-Maps , 2011, PloS one.

[18]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[19]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[20]  B. Cairns,et al.  DNA Demethylation in Zebrafish Involves the Coupling of a Deaminase, a Glycosylase, and Gadd45 , 2008, Cell.

[21]  S. Goodman,et al.  Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. , 2002, Journal of the National Cancer Institute.

[22]  M. Letarte,et al.  B-lineage colonies from normal, human bone marrow are initiated by B cells and their progenitors. , 1991, Blood.

[23]  A. Valencia,et al.  The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. , 2008, Genome research.

[24]  J. Minárovits,et al.  High-resolution analysis of CpG methylation and in vivo protein–DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1 , 2007, Virus Genes.

[25]  Michelle M. Sandau,et al.  Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation , 2008, Nature Immunology.

[26]  C. Woodman,et al.  Epigenetic and Transcriptional Changes Which Follow Epstein-Barr Virus Infection of Germinal Center B Cells and Their Relevance to the Pathogenesis of Hodgkin's Lymphoma , 2007, Journal of Virology.

[27]  M. Gerstein,et al.  Variation in Transcription Factor Binding Among Humans , 2010, Science.

[28]  R. Kuick,et al.  Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2. , 2000, Human molecular genetics.

[29]  Z. Estrov,et al.  Autocrine lymphotoxin production in Epstein–Barr virus-immortalized B cells: induction via NF-κB activation mediated by EBV-derived latent membrane protein 1 , 2003, Leukemia.

[30]  Robert E. White,et al.  Epstein-Barr Virus Latency in B Cells Leads to Epigenetic Repression and CpG Methylation of the Tumour Suppressor Gene Bim , 2009, PLoS pathogens.

[31]  Michael Q. Zhang,et al.  Statistical significance of cis-regulatory modules. , 2007, BMC bioinformatics.

[32]  Andreas Prlic,et al.  Ensembl 2007 , 2006, Nucleic Acids Res..

[33]  W. Hammerschmidt,et al.  Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Klein-Szanto,et al.  Thymine DNA Glycosylase Is Essential for Active DNA Demethylation by Linked Deamination-Base Excision Repair , 2011, Cell.

[35]  E. Kieff,et al.  Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Nussenzweig,et al.  Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes , 2011, Nature Immunology.

[37]  H. Schild,et al.  EBV-Induced Gene 3 Transcription Is Induced by TLR Signaling in Primary Dendritic Cells via NF-κB Activation , 2005, The Journal of Immunology.

[38]  A. Bird,et al.  CpG islands and the regulation of transcription. , 2011, Genes & development.

[39]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[40]  D. Thorley-Lawson,et al.  Epstein-Barr virus: exploiting the immune system , 2001, Nature Reviews Immunology.

[41]  Elliott Kieff,et al.  Role of NF-κB in Cell Survival and Transcription of Latent Membrane Protein 1-Expressing or Epstein-Barr Virus Latency III-Infected Cells , 2004, Journal of Virology.

[42]  K. Rajewsky,et al.  Cellular origin of human B-cell lymphomas. , 1999, The New England journal of medicine.

[43]  Fatima Al-Shahrour,et al.  Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. , 2010, Genome research.

[44]  John Quackenbush,et al.  Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth , 2011, Proceedings of the National Academy of Sciences.

[45]  D. Allen,et al.  The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM , 1998, Nature.

[46]  Yoav Gilad,et al.  The effects of EBV transformation on gene expression levels and methylation profiles. , 2011, Human molecular genetics.

[47]  L. Vives,et al.  Genome-wide tracking of unmethylated DNA Alu repeats in normal and cancer cells , 2007, Nucleic acids research.

[48]  Irving L. Weissman,et al.  A comprehensive methylome map of lineage commitment from hematopoietic progenitors , 2010, Nature.

[49]  A. Rickinson,et al.  Epstein-Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth. , 2005, The Journal of general virology.

[50]  Yi Zhang,et al.  Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. , 2011, Genes & development.

[51]  Y. Kaneda,et al.  DNA methyltransferase 3b preferentially associates with condensed chromatin , 2010, Nucleic acids research.

[52]  Barbara J. Graves,et al.  DNA Specificity Determinants Associate with Distinct Transcription Factor Functions , 2009, PLoS genetics.

[53]  M. Pender.  Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. , 2003, Trends in immunology.

[54]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[55]  L. Young,et al.  Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.

[56]  J. Hagman,et al.  B lymphocyte lineage specification, commitment and epigenetic control of transcription by early B cell factor 1. , 2012, Current topics in microbiology and immunology.

[57]  E. Robertson,et al.  Epstein-Barr Virus–Associated B-cell Lymphomas: Pathogenesis and Clinical Outcomes , 2011, Clinical Cancer Research.